Evaluation of a multiple system atrophy model in rats using multitracer microPET

Acta Neurochirurgica

Volumn 154, Issue 5, 2012, Pages 935-940

  Yoon, Hyung Ho ^a   Lee, Chong Sik ^a   Hong, Seok Ho ^a   Min, Joongkee ^a   Kim, Yong Hwan ^b   Hwang, Onyou ^a   Jeon, Sang Ryong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Notre Dame   (United States)

Author keywords

Dopamine transporter; Double toxin doublelesion; FP CIT PET; Glucose metabolism; MSA p; Multiple system atrophy; Positron emission tomography; Striatonigral degeneration

Indexed keywords

APOMORPHINE; CRYSTAL VIOLET; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; N (3 FLUOROPROPYL) 2 CARBOMETHOXY 3 (4 IODOPHENYL)NORTROPANE F 18; OXIDOPAMINE; QUINOLINIC ACID; TRACER; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; CORPUS STRIATUM; FOLLOW UP; GLUCOSE METABOLISM; HISTOLOGY; MALE; MEDIAL FOREBRAIN BUNDLE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ROTAROD TEST; SHY DRAGER SYNDROME; STAINING; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MOTOR ACTIVITY; MULTIPLE SYSTEM ATROPHY; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA;

EID: 84862697916     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-011-1133-z     Document Type: Article

References (19)

1. Adams RD, Vanbogaert L, Vandereecken H (1964) Striato-nigral degeneration. J Neuropathol Exp Neurol 23:584-608
2. Alexi T, Venero J, Hefti F (1997) Protective effects of neurotrophin-4/5 and transforming growth factor-[alpha] on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid. Neuroscience 78:73-86
3. Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, Gunther I (1997) Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 120:2187
4. Battisti JJ, Uretsky NJ, Wallace LJ (1999) Sensitization of apomorphine-induced stereotyped behavior in mice is context dependent. Psychopharmacology 146:42-48
5. Casteels C, Lauwers E, Bormans G, Baekelandt V, Van Laere K (2008) Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Eur J Nucl Med Mol Imaging 35:124-134
6. Churchyard A, Donnan G, Hughes A, Howells D, Woodhouse D, Wong J, Kalnins R, Mendelsohn F, PaxinosG(1993) Dopa resistance in multiple system atrophy: Loss of postsynaptic D2 receptors. Ann Neurol 34:219-226
7. Fernagut PO, Ghorayeb I, Diguet E, Tison F (2005) In vivo models of multiple system atrophy. Mov Disord 20:S57-S63
8. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD (2002) Differentiating multiple system atrophy from Parkinson"s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 73:517
9. Hwang O, Baker H, Gross S, Joh TH (1998) Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide producing cells. Synapse 28:140-153
10. Kim JS, Lee JS, Im KC, Kim SJ, Kim SY, Lee DS, Moon DH (2007) Performance measurement of the microPET Focus 120 scanner. J Nucl Med 48:1527
11. Kollensperger M, Stefanova N, Pallua A, Puschban Z, Dechant G, Hainzer M, Reindl M, Poewe W, Nikkhah G, Wenning GK (2009) Striatal transplantation in a rodent model of multiple system atrophy: effects on L Dopa response. J Neurosci Res 87:1679-1685
12. Lee CS, Cenci MA, Schulzer M, Bjorklund A (2000) Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 123:1365
13. Lee H, Park I, Kim H, Kim S (2009) Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage. Gene Ther 16:1066-1076
14. Mizoguchi K, Ikeda R, Shoji H, Tanaka Y, Tabira T (2008) Suppression of glucocorticoid secretion induces a behaviorally depressive state in rotarod performance in rat. Pharmacol Biochem Behav 90:730-734
15. Moresco R, Lavazza T, Belloli S, Lecchi M, Pezzola A, Todde S, Matarrese M, Carpinelli A, Turolla E, Zimarino V (2008) Quinolinic acid induced neurodegeneration in the striatum: A combined in vivo and in vitro analysis of receptor changes and microglia activation. Eur J Nucl Med Mol Imaging 35:704-715
16. Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn N, Jenner P, Poewe W, Wenning G (1999) Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Neuroscience 95:377-388
17. Schober A (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318:215-224
18. Wenning G, Ben-Shlomo Y, Hughes A, Daniel S, Lees A, Quinn N (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 68:434
19. Wenning G, Granata R, Laboyrie P, Quinn N, Jenner P, Marsden C (1996) Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov Disord 11:522-532